£1 million award for BactiVac network to continue supporting development of bacterial vaccines

  22 February 2023

Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease. 

BactiVac, the Bacterial Vaccines Network, has secured £1 million of funding from Wellcome to accelerate the development of bacterial vaccines and combat the threat of antimicrobial resistance (AMR).

Further reading: University of Birmingham
Author(s): University of Birmingham
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed